Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
- 24 February 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet Haematology
- Vol. 7 (4), e284-e294
- https://doi.org/10.1016/s2352-3026(19)30283-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 studyBlood, 2011
- Extranodal Natural-Killer/T-Cell Lymphoma, Nasal TypeAdvances in Hematology, 2010
- Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211Journal of Clinical Oncology, 2009
- Advances in the management and monitoring of extranodal NK/T‐cell lymphoma, nasal typeBritish Journal of Haematology, 2009
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma ProjectBlood, 2009
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical OutcomesJournal of Clinical Oncology, 2008
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Analyses of dose–response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classificationRadiotherapy and Oncology, 2006
- Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter StudyJournal of Clinical Oncology, 2006
- Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell LymphomaJournal of Clinical Oncology, 2006